Citation Impact
Citing Papers
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Cancer Pharmacogenomics in Children: Research Initiatives and Progress to Date
2013
Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
2007
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity
2011
Microfluidic organs-on-chips
2014 Standout
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
Target-based selection of flavonoids for neurodegenerative disorders
2012
Cisplatin: The first metal based anticancer drug
2019 Standout
A Tri‐copper(II) Complex Displaying DNA‐Cleaving Properties and Antiproliferative Activity against Cancer Cells
2012
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
2017
Mucous Membrane Pemphigoid
2013
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
2010
Cisplatin nephrotoxicity: a review of the literature
2017
Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
2012
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Clinical Uses of Melatonin in Pediatrics
2011
Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies
2015
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Mitigation of acute kidney injury by cell-cycle inhibitors that suppress both CDK4/6 and OCT2 functions
2015
Ototoxicity and cancer therapy
2016
Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies
2009
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
2011
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
2013 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
2013
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Mechanisms of Renal Fibrosis
2017 Standout
Works of Dirk Deuster being referenced
Voice deepening under testosterone treatment in female-to-male gender dysphoric individuals
2015
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
2007
Melatonin is a Useful Alternative to Sedation in Children Undergoing Brainstem Audiometry with an Age Dependent Success Rate - A Field Report of 250 Investigations
2007
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
2010
Therapeutic effect of etanercept in anti‐laminin 5 (laminin 332) mucous membrane pemphigoid
2011
Continuous or repeated prolonged cisplatin infusions in children: A prospective study on ototoxicity, platinum concentrations, and standard serum parameters
2005
Die „Münsteraner Klassifikation“
2006
Human OCT2 Variant C.808G>T Confers Protection Effect Against Cisplatin-Induced Ototoxicity
2015